Literature DB >> 11222558

Effect of hydrophobicity and molecular mass on the accumulation of fluoroquinolones by Staphylococcus aureus.

L J Piddock1, Y F Jin, D J Griggs.   

Abstract

Ten novel fluoroquinolones, with similar chemical structures but differing antibacterial activities and hydrophobicities, were studied to evaluate the role of the physical properties of quinolones on their accumulation and antibacterial activity for Staphylococcus aureus. Six of the 10 agents and tosufloxacin were more active against quinolone-susceptible and -resistant S. aureus than the remaining four agents and several piperazinyl fluoroquinolones. Changes to the side chains of the pyrollidinyl substituent at the R7 position alone made little difference to the MICs. Comparison of MICs of agents that were structurally identical apart from the R1 substituents, confirmed that a t-butyl group confers enhanced activity against S. aureus over a cyclopropyl or ethyl group at this position. The steady-state concentrations (SSCs) of the 10 novel quinolones accumulated by wild-type S. aureus did not correlate with their MICs or chemical structures. There was no apparent relationship between logP of the quinolone and accumulation by S. aureus F77; however, accumulation was positively correlated with molecular mass for 9/10 agents (r = 0.745) confirming that high molecular mass is not a barrier to accumulation in S. aureus. For all 10 agents, the presence of carbonyl cyanide m-chlorophenylhydrazone (CCCP) increased the concentration of quinolone accumulated by SA-1199, suggesting that NorA was inhibited. The fold increase of the SSC in the presence of CCCP did not correlate with hydrophobicity, but the SSC of agents with either an ethyl or cyclopropyl group at R1 was increased two- to three-fold in the presence of CCCP, suggesting that affinity for the NorA efflux pump may be influenced by quinolone structure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222558     DOI: 10.1093/jac/47.3.261

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  17 in total

Review 1.  Mode of action of microbial bioactive metabolites.

Authors:  V Bethal
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

Review 2.  Defining new chemical space for drug penetration into Gram-negative bacteria.

Authors:  Shibin Zhao; Justyna W Adamiak; Vincent Bonifay; Jitender Mehla; Helen I Zgurskaya; Derek S Tan
Journal:  Nat Chem Biol       Date:  2020-11-16       Impact factor: 15.040

3.  Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.

Authors:  S Raherison; P Gonzalez; H Renaudin; A Charron; C Bébéar; C M Bébéar
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

4.  Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus.

Authors:  Hidemasa Nakaminami; Norihisa Noguchi; Masanori Sasatsu
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

5.  Bone-targeting of quinolones conjugated with an acidic oligopeptide.

Authors:  Tatsuo Takahashi; Koichi Yokogawa; Naoki Sakura; Masaaki Nomura; Shinjiro Kobayashi; Ken-ichi Miyamoto
Journal:  Pharm Res       Date:  2008-07-29       Impact factor: 4.200

6.  Factor analysis of microbiological activity data and structural parameters of antibacterial quinolones.

Authors:  Marcin Koba; Tomasz Baczek; Katarzyna Macur; Leszek Bober; Teresa Frackowiak; Adam Buciński; Danuta Rystok-Grabska; Jolanta Stasiak; Katarzyna Koba
Journal:  J Mol Model       Date:  2009-07-15       Impact factor: 1.810

7.  Pseudomonas aeruginosa PAO1 resistance to Zinc pyrithione: phenotypic changes suggest the involvement of efflux pumps.

Authors:  Suzanne M Abdel Malek; Ibrahim S Al-Adham; Khalid Z Matalka; Philip J Collier
Journal:  Curr Microbiol       Date:  2009-05-19       Impact factor: 2.188

8.  Alterations in the Quinolone Resistance-Determining Regions and Fluoroquinolone Resistance in Clinical Isolates and Laboratory-Derived Mutants of Mycoplasma bovis: Not All Genotypes May Be Equal.

Authors:  Dima Khalil; Claire A M Becker; Florence Tardy
Journal:  Appl Environ Microbiol       Date:  2015-12-04       Impact factor: 4.792

9.  Pharmacological characterization of 7-(4-(Piperazin-1-yl)) ciprofloxacin derivatives: antibacterial activity, cellular accumulation, susceptibility to efflux transporters, and intracellular activity.

Authors:  Béatrice Marquez; Vincent Pourcelle; Coralie M Vallet; Marie-Paule Mingeot-Leclercq; Paul M Tulkens; Jacqueline Marchand-Bruynaert; Françoise Van Bambeke
Journal:  Pharm Res       Date:  2013-12-05       Impact factor: 4.200

10.  Performance evaluation of non-ionic silicone surfactants OFX 0309 and DC 193C as a new approach in cloud point extraction - spectrophotometry for determination of atrazine in water samples.

Authors:  N I Mohd; M Raoov; S Mohamad; N N M Zain
Journal:  RSC Adv       Date:  2018-04-11       Impact factor: 4.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.